GFS Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.5M | Sell |
79,014
-448
| -0.6% | -$51.7K | 1.21% | 29 |
|
|
2025
Q4 | $8.36M | Sell |
79,462
-52,355
| -40% | -$4.91M | 0.99% | 35 |
|
|
2025
Q3 | $11.1M | Buy |
131,817
+3
| +0% | +$247 | 1.41% | 20 |
|
|
2025
Q2 | $10.4M | Buy |
131,814
+49,440
| +60% | +$3.93M | 1.43% | 24 |
|
|
2025
Q1 | $7.39M | Sell |
82,374
-187
| -0.2% | -$17.5K | 1.48% | 25 |
|
|
2024
Q4 | $8.21M | Buy |
82,561
+1,675
| +2% | +$173K | 1.25% | 28 |
|
|
2024
Q3 | $9.19M | Buy |
80,886
+79,926
| +8,326% | +$9.5M | 1.95% | 20 |
|
|
2024
Q2 | $9.75M | Sell |
960
-80,984
| -99% | -$10.4M | 1.57% | 23 |
|
|
2024
Q1 | $10.8M | Sell |
81,944
-1,486
| -2% | -$183K | 1.79% | 19 |
|
|
2023
Q4 | $9.1M | Buy |
83,430
+368
| +0.4% | +$38.2K | 1.33% | 28 |
|
|
2023
Q3 | $8.55M | Buy |
83,062
+24,801
| +43% | +$2.67M | 1.33% | 29 |
|
|
2023
Q2 | $6.72M | Hold |
58,261
| – | – | 1.49% | 20 |
|
|
2023
Q1 | $6.2M | Sell |
58,261
-3,000
| -5% | -$324K | 1.43% | 23 |
|
|
2022
Q4 | $6.8M | Sell |
61,261
-390
| -0.6% | -$39.9K | 1.53% | 25 |
|
|
2022
Q3 | $5.31M | Sell |
61,651
-782
| -1% | -$69.8K | 1.27% | 28 |
|
|
2022
Q2 | $5.69M | Sell |
62,433
-69,347
| -53% | -$6.15M | 1.27% | 28 |
|
|
2022
Q1 | $10.8M | Sell |
131,780
-28,500
| -18% | -$2.25M | 2.28% | 11 |
|
|
2021
Q4 | $12.3M | Buy |
160,280
+42,315
| +36% | +$3.37M | 2.03% | 12 |
|
|
2021
Q3 | $8.86M | Buy |
117,965
+6,755
| +6% | +$514K | 1.93% | 15 |
|
|
2021
Q2 | $8.65M | Sell |
111,210
-1,288
| -1% | -$95.8K | 1.95% | 15 |
|
|
2021
Q1 | $8.28M | Sell |
112,498
-3,091
| -3% | -$228K | 1.93% | 18 |
|
|
2020
Q4 | $9.02M | Buy |
115,589
+230
| +0.2% | +$17.6K | 2.37% | 11 |
|
|
2020
Q3 | $9.13M | Buy |
115,359
+15,359
| +15% | +$1.2M | 2.78% | 8 |
|
|
2020
Q2 | $7.38M | Buy |
100,000
+60,334
| +152% | +$4.54M | 2.28% | 14 |
|
|
2020
Q1 | $2.91M | Buy |
39,666
+14,819
| +60% | +$1.16M | 0.91% | 26 |
|
|
2019
Q4 | $2.16M | Hold |
24,847
| – | – | 0.56% | 46 |
|
|
2019
Q3 | $2M | Buy |
24,847
+272
| +1% | +$21.8K | 0.56% | 48 |
|
|
2019
Q2 | $1.97M | Hold |
24,575
| – | – | 0.56% | 44 |
|
|
2019
Q1 | $1.95M | Hold |
24,575
| – | – | 0.58% | 40 |
|
|
2018
Q4 | $1.79M | Sell |
24,575
-209
| -0.8% | -$14.8K | 0.48% | 47 |
|
|
2018
Q3 | $1.68M | Sell |
24,784
-79,250
| -76% | -$5.05M | 0.43% | 51 |
|
|
2018
Q2 | $6.03M | Buy |
104,034
+1,074
| +1% | +$60.6K | 1.25% | 27 |
|
|
2018
Q1 | $5.35M | Buy |
102,960
+2,508
| +2% | +$135K | 1.11% | 26 |
|
|
2017
Q4 | $5.39M | Buy |
100,452
+43,086
| +75% | +$2.39M | 1.17% | 26 |
|
|
2017
Q3 | $3.5M | Sell |
57,366
-159
| -0.3% | -$9.64K | 0.79% | 31 |
|
|
2017
Q2 | $3.52M | Buy |
57,525
+4,926
| +9% | +$300K | 0.76% | 33 |
|
|
2017
Q1 | $3.19M | Buy |
52,599
+11,045
| +27% | +$670K | 0.66% | 40 |
|
|
2016
Q4 | $2.33M | Sell |
41,554
-3,983
| -9% | -$233K | 0.49% | 46 |
|
|
2016
Q3 | $2.71M | Buy |
45,537
+7,651
| +20% | +$447K | 0.6% | 43 |
|
|
2016
Q2 | $2.08M | Sell |
37,886
-16,349
| -30% | -$870K | 0.5% | 51 |
|
|
2016
Q1 | $2.74M | Hold |
54,235
| – | – | 0.72% | 39 |
|
|
2015
Q4 | $2.73M | Hold |
54,235
| – | – | 0.81% | 38 |
|
|
2015
Q3 | $2.56M | Buy |
54,235
+3,563
| +7% | +$189K | 0.88% | 38 |
|
|
2015
Q2 | $2.75M | Sell |
50,672
-157
| -0.3% | -$8.8K | 0.91% | 36 |
|
|
2015
Q1 | $2.79M | Buy |
50,829
+4,506
| +10% | +$255K | 0.98% | 33 |
|
|
2014
Q4 | $2.51M | Hold |
46,323
| – | – | 1% | 35 |
|
|
2014
Q3 | $2.62M | Hold |
46,323
| – | – | 1.09% | 29 |
|
|
2014
Q2 | $2.56M | Hold |
46,323
| – | – | 1.04% | 30 |
|
|
2014
Q1 | $2.51M | Sell |
46,323
-133
| -0.3% | -$6.89K | 0.99% | 33 |
|
|
2013
Q4 | $2.22M | Hold |
46,456
| – | – | 1.1% | 29 |
|
|
2013
Q3 | $2.11M | Buy |
46,456
+151
| +0.3% | +$6.89K | 1.12% | 28 |
|
|
2013
Q2 | $2.05M | Buy |
+46,305
| New | +$2.07M | 1.19% | 26 |
|
Other funds holding MRK
VCM
VPM
GFS Advisors's MRK Position: Q1 2026 in Review
GFS Advisors reduced its Merck (MRK) stake by 0.56% in Q1 2026, selling an estimated $51.7K and leaving 79,014 shares worth $9.5M. The position accounts for 1.21% of the portfolio, ranked #29.
GFS Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.3M in Q4 2021. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- GFS Advisors held 79,014 shares of Merck worth $9.5M as of Q1 2026.
- GFS Advisors sold 448 Merck shares in Q1 2026, an estimated $51.7K.
- Merck made up 1.21% of GFS Advisors's portfolio in Q1 2026, its #29 holding.
- GFS Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- GFS Advisors's Merck position peaked at $12.3M in Q4 2021.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on GFS Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.